Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Isis Pharmaceuticals Inc ISIS

Sector: Healthcare | Sub-Sector: Biotechnology

Isis Pharmaceuticals is engaged in antisense drug discovery and development, exploiting a novel drug discovery platform it created to generate a broad pipeline of first-in-class drugs.
Price: $31.39 | Change: +$1.46 | %Change: +4.88%
Volume: 2.0m | Day High/Low: 31.60/30.26 | 52 Week High/Low: 62.66/22.25

Snapshot

Last Traded: July 23, 2014 12:06 Transaction Volume: 2.0m
Open: $31.39 Previous Close: $29.93
Bid: $27.54 Ask: $33.63
Bid Size: 200 Ask Size: 100
Market Cap: $3.7b Shares Out: 117.6m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • VP exercised options

    0 stars

    A vice president of Isis Pharmaceuticals Inc. exercised options for 12,200 shares of common stock and sold them under a prearranged...

    1 star


  • news and potential uptrend

    0 stars

    Isis Pharmaceuticals last week reported a sharp drop in its net loss for 2007 despite higher operating expenses as the company...

    1 star


  • Overview of the stock

    0 stars

    Here are some points to consider:1) Biotech industry is very volatile though ISIS stock prices started accelerating upwards in August and...

    0 stars


  • isis needs a kiss of life

    0 stars

    Maybe Tobin is the volunteer...trading on the 27th April,07 @ $10.22

    2.5 stars


  • Tobin Smith is pumping ISIS presently

    0 stars

    Wow, I can't believe that no one has left a message on this board since 2003. Toby Smith (Tobin) is calling this one a major buy-out...

    0 stars